Annual SG&A
$8.08 M
+$2.73 M+50.85%
01 December 2023
Summary:
Reviva Pharmaceuticals Holdings annual selling, general & administrative expenses is currently $8.08 million, with the most recent change of +$2.73 million (+50.85%) on 01 December 2023. During the last 3 years, it has risen by +$5.94 million (+277.84%). RVPH annual SG&A is now at all-time high.RVPH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.60 M
-$941.10 K-36.97%
01 September 2024
Summary:
Reviva Pharmaceuticals Holdings quarterly selling, general & administrative expenses is currently $1.60 million, with the most recent change of -$941.10 thousand (-36.97%) on 01 September 2024. Over the past year, it has dropped by -$387.60 thousand (-19.46%). RVPH quarterly SG&A is now -47.90% below its all-time high of $3.08 million, reached on 30 June 2023.RVPH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$583.80 M
-$37.31 M-6.83%
01 September 2024
Summary:
Reviva Pharmaceuticals Holdings TTM selling, general & administrative expenses is currently -$583.80 million, with the most recent change of -$37.31 million (-6.83%) on 01 September 2024. Over the past year, it has dropped by -$591.85 million (-7353.84%). RVPH TTM SG&A is now -339520.64% below its all-time high of $8.72 million, reached on 01 March 2024.RVPH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVPH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.9% | -19.5% | -7353.8% |
| 3 y3 years | +277.8% | +52.3% | -10000.0% |
| 5 y5 years | - | - | - |
RVPH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +277.8% | -47.9% | +59.6% | -141.7% | at low |
| 5 y | 5 years | at high | +4363.7% | -47.9% | +362.3% | <-9999.0% | at low |
| alltime | all time | at high | +4363.7% | -47.9% | +362.3% | <-9999.0% | at low |
Reviva Pharmaceuticals Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.60 M(-37.0%) | $7.80 M(-4.7%) |
| June 2024 | - | $2.55 M(+19.0%) | $8.19 M(-6.1%) |
| Mar 2024 | - | $2.14 M(+41.4%) | $8.72 M(+7.9%) |
| Dec 2023 | $8.08 M(+50.9%) | $1.51 M(-24.1%) | $8.08 M(+0.4%) |
| Sept 2023 | - | $1.99 M(-35.3%) | $8.05 M(+10.0%) |
| June 2023 | - | $3.08 M(+105.2%) | $7.31 M(+39.6%) |
| Mar 2023 | - | $1.50 M(+1.6%) | $5.24 M(-2.2%) |
| Dec 2022 | $5.36 M | $1.48 M(+17.5%) | $5.36 M(+3.4%) |
| Sept 2022 | - | $1.26 M(+25.1%) | $5.18 M(+4.1%) |
| June 2022 | - | $1.01 M(-38.0%) | $4.98 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.62 M(+24.4%) | $5.39 M(+2.6%) |
| Dec 2021 | $5.25 M(+145.5%) | $1.30 M(+23.6%) | $5.25 M(+17.3%) |
| Sept 2021 | - | $1.05 M(-25.6%) | $4.48 M(+13.8%) |
| June 2021 | - | $1.42 M(-4.4%) | $3.93 M(+20.7%) |
| Mar 2021 | - | $1.48 M(+181.2%) | $3.26 M(+53.3%) |
| Dec 2020 | $2.14 M(+1081.4%) | $526.70 K(+3.0%) | $2.13 M(+32.9%) |
| Sept 2020 | - | $511.30 K(-31.0%) | $1.60 M(+47.0%) |
| June 2020 | - | $740.90 K(+113.5%) | $1.09 M(+213.5%) |
| Mar 2020 | - | $347.00 K | $347.00 K |
| Dec 2019 | $181.10 K | - | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual SG&A year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly SG&A year-on-year change?
- What is Reviva Pharmaceuticals Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings TTM SG&A year-on-year change?
What is Reviva Pharmaceuticals Holdings annual selling, general & administrative expenses?
The current annual SG&A of RVPH is $8.08 M
What is the all time high annual SG&A for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual selling, general & administrative expenses is $8.08 M
What is Reviva Pharmaceuticals Holdings annual SG&A year-on-year change?
Over the past year, RVPH annual selling, general & administrative expenses has changed by +$2.73 M (+50.85%)
What is Reviva Pharmaceuticals Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of RVPH is $1.60 M
What is the all time high quarterly SG&A for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly selling, general & administrative expenses is $3.08 M
What is Reviva Pharmaceuticals Holdings quarterly SG&A year-on-year change?
Over the past year, RVPH quarterly selling, general & administrative expenses has changed by -$387.60 K (-19.46%)
What is Reviva Pharmaceuticals Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of RVPH is -$583.80 M
What is the all time high TTM SG&A for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high TTM selling, general & administrative expenses is $8.72 M
What is Reviva Pharmaceuticals Holdings TTM SG&A year-on-year change?
Over the past year, RVPH TTM selling, general & administrative expenses has changed by -$591.85 M (-7353.84%)